← Back
Data updated: Mar 10, 2026
ABLE
Infectious DiseaseCardiovascularImmunology
ABLE is a generic drug manufacturer focused on Infectious Disease, Cardiovascular, Immunology.
1987
Since
28
Drugs
-
Trials
443
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-13
NAPROXEN SODIUM 2026-01-24
Labeling
NAPROXEN SODIUM 2026-01-24
Labeling
NAPROXEN SODIUM 2026-01-24
Labeling
NAPROXEN SODIUM 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 40%
0 drugs Phase 3: 2
Cardiovascular 30%
1 drugs
Immunology 30%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Merck big-pharma
Infectious Disease, Cardiovascular, Immunology
Johnson & Johnson big-pharma
Immunology, Infectious Disease, Cardiovascular
COSETTE other
Cardiovascular, Infectious Disease, Immunology
BAUSCH AND LOMB specialty
Cardiovascular, Infectious Disease, Immunology
Pfizer big-pharma
Infectious Disease, Immunology
Active (9)
Discontinued (19)
METRONIDAZOLE HYDROCODONE BITARTRATE AND ACETAMINOPHEN ACETAMINOPHEN AND CODEINE PHOSPHATE HYDROXYZINE HYDROCHLORIDE ACETAMINOPHEN LITHIUM CARBONATE DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE CLORAZEPATE DIPOTASSIUM PHENTERMINE HYDROCHLORIDE INDOMETHACIN PROMETHAZINE HYDROCHLORIDE THEOPHYLLINE METHOCARBAMOL PROCHLORPERAZINE CARISOPRODOL BETHANECHOL CHLORIDE PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE HEMSOL-HC
Company Info
- First Approval
- 1987-06-26
- Latest
- 2005-06-24
- Applications
- 62